168 related articles for article (PubMed ID: 17956820)
21. Microbiological profile of haematogenous osteoarticular infections in children.
Trifa M; Bouchoucha S; Smaoui H; Frikha M; Ben Marzouk S; Ben Ghachem M; Kechrid A; Fekih Hassen A; Ben Khalifa S
Orthop Traumatol Surg Res; 2011 Apr; 97(2):186-90. PubMed ID: 21371961
[TBL] [Abstract][Full Text] [Related]
22. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
23. Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial.
Peltola H; Pääkkönen M; Kallio P; Kallio MJ;
Clin Microbiol Infect; 2012 Jun; 18(6):582-9. PubMed ID: 22011265
[TBL] [Abstract][Full Text] [Related]
24. Bone and joint infections.
Pääkkönen M; Peltola H
Pediatr Clin North Am; 2013 Apr; 60(2):425-36. PubMed ID: 23481109
[TBL] [Abstract][Full Text] [Related]
25. Experience with linezolid therapy in children with osteoarticular infections.
Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
[TBL] [Abstract][Full Text] [Related]
26. Beta-lactam antibiotic susceptibility testing of MRSA?
Agrawal G; Jalgaonkar SV
Indian J Med Microbiol; 2006 Oct; 24(4):304. PubMed ID: 17185859
[No Abstract] [Full Text] [Related]
27. [Osteoarticular infections with staphylococcus aureus secreting Panton-Valentine leucocidin].
Gillet Y; Dohin B; Dumitrescu O; Lina G; Vandenesch F; Etienne J; Floret D
Arch Pediatr; 2007 Oct; 14 Suppl 2():S102-7. PubMed ID: 17956817
[TBL] [Abstract][Full Text] [Related]
28. Clindamycin resistance among Staphylococcus aureus strains in Israel: implications for empirical treatment of skin and soft tissue infections.
Stein M; Komerska J; Prizade M; Sheinberg B; Tasher D; Somekh E
Int J Infect Dis; 2016 May; 46():18-21. PubMed ID: 26987479
[TBL] [Abstract][Full Text] [Related]
29. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.
Ng J; Gosbell IB
J Antimicrob Chemother; 2005 Jun; 55(6):1008-12. PubMed ID: 15845784
[TBL] [Abstract][Full Text] [Related]
30. Assessment of methicillin and clindamycin resistance patterns in Staphylococcus aureus isolated from a tertiary hospital in Turkey.
Tekin A; Dal T; Deveci O; Tekin R; Atmaca S; Dayan S
Infez Med; 2013 Jun; 21(2):111-6. PubMed ID: 23774974
[TBL] [Abstract][Full Text] [Related]
31. In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
Yu Y; Zhou YF; Chen MR; Li X; Qiao GL; Sun J; Liao XP; Liu YH
PLoS One; 2016; 11(5):e0156273. PubMed ID: 27218674
[TBL] [Abstract][Full Text] [Related]
32. [Osteoarticular infections: therapeutic proposals of the Paediatric Infectious Diseases Group of the French Society of Paediatrics (GPIP)].
Grimprel E; Lorrot M; Haas H; Pinquier D; Parez N; Ferroni A; Cohen R;
Arch Pediatr; 2008 Oct; 15 Suppl 2():S74-80. PubMed ID: 19000859
[TBL] [Abstract][Full Text] [Related]
33. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
[TBL] [Abstract][Full Text] [Related]
34. [Staphylococcus aureus infections--the clinical picture and treatment].
Gahrn-Hansen B; Espersen F; Frimodt-Møller N; Riegels-Nielsen P; Pedersen SS
Ugeskr Laeger; 2002 Aug; 164(32):3759-63. PubMed ID: 12362608
[TBL] [Abstract][Full Text] [Related]
35. High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4).
Hamilton SM; Alexander JAN; Choo EJ; Basuino L; da Costa TM; Severin A; Chung M; Aedo S; Strynadka NCJ; Tomasz A; Chatterjee SS; Chambers HF
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373193
[TBL] [Abstract][Full Text] [Related]
36. Changing Susceptibility of Staphylococcus aureus in a US Pediatric Population.
Sutter DE; Milburn E; Chukwuma U; Dzialowy N; Maranich AM; Hospenthal DR
Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26933211
[TBL] [Abstract][Full Text] [Related]
37. Beta-lactam therapy of osteomyelitis and septic arthritis.
Wilber RB
Scand J Infect Dis Suppl; 1984; 42():155-68. PubMed ID: 6396837
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
Marsot A
J Pharm Pharm Sci; 2020; 23():470-485. PubMed ID: 33227230
[TBL] [Abstract][Full Text] [Related]
39. Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.
Soyletir G; Altinkanat G; Gur D; Altun B; Tunger A; Aydemir S; Kayacan C; Aktas Z; Gunaydin M; Karadag A; Gorur H; Morrissey I; Torumkuney D
J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i71-83. PubMed ID: 27048584
[TBL] [Abstract][Full Text] [Related]
40. Can beta-lactams be re-engineered to beat MRSA?
Livermore DM
Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():11-6. PubMed ID: 16524423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
